Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
93 studies found for:    Open Studies | "Mesothelioma"
Show Display Options
Rank Status Study
1 Recruiting A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma
Condition: Pleural Mesothelioma
Interventions: Drug: Pembrolizumab;   Drug: Cisplatin and Pemetrexed
2 Recruiting PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma
Condition: Mesothelioma
Intervention: Radiation: Prophylactic Irradiation of Tracts (PIT)
3 Not yet recruiting Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma
Conditions: Mesothelioma;   Pleural Mesothelioma
Interventions: Drug: Concurrent Durvalumab;   Drug: Maintenance Durvalumab
4 Not yet recruiting Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment
Condition: Mesothelioma
Intervention: Drug: Oshadi D and Oshadi R
5 Recruiting Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Condition: Mesothelioma
Intervention:
6 Recruiting Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Cisplatin;   Drug: Pemetrexed;   Drug: Pembrolizumab
7 Recruiting Intrapleural Cryotherapy for Malignant Pleural Mesothelioma
Condition: Mesothelioma
Interventions: Device: Cryotherapy;   Other: Control
8 Not yet recruiting Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention: Other: CD 74, VEGF detection
9 Recruiting ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: Trabectedin
10 Recruiting Dendritic Cells Loaded With Allogeneous Cell Lysate in Mesothelioma Patients
Condition: Mesothelioma
Intervention: Biological: MesoCancerVac
11 Recruiting MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma
Condition: Mesothelioma
Interventions: Drug: MEDI4736;   Drug: Tremelimumab;   Other: Untreated arm (control)
12 Recruiting Nintedanib (BIBF 1120) in Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Nintedanib;   Drug: Pemetrexed;   Drug: Cisplatin;   Drug: Placebo
13 Recruiting Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)
Condition: Mesothelioma
Interventions: Drug: Anetumab ravtansine (BAY 94-9343);   Drug: Vinorelbine
14 Recruiting Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients
Condition: Mesothelioma
Interventions: Biological: Nivolumab;   Biological: Ipilimumab;   Drug: Pemetrexed;   Drug: Cisplatin;   Drug: Carboplatin
15 Recruiting Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma
Condition: Mesothelioma
Interventions: Procedure: Pleurectomy/Decortication;   Drug: pemetrexed and cisplatin or carboplatin;   Radiation: Intensity Modulated Radiation Therapy
16 Recruiting Window of Opportunity Study of VS-6063 (Defactinib) in Participants With Surgical Resectable Malignant Pleural Mesothelioma.
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: VS-6063
17 Recruiting Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Interventions: Device: photodynamic therapy (PDT);   Procedure: thoracic surgery Pleurectomy / extended Decortication;   Drug: Adjuvant chemotherapy
18 Recruiting MARS 2: A Feasibility Study Comparing (Extended) Pleurectomy Decortication Versus no Pleurectomy Decortication in Patients With Malignant Pleural Mesothelioma
Condition: Mesothelioma
Intervention: Procedure: (Extended) pleurectomy decortication
19 Recruiting 11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM)
Condition: Mesothelioma, Malignant
Intervention: Other: No intervention
20 Recruiting A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy
Condition: Malignant Pleural Mesothelioma (MPM)
Intervention: Biological: Multipeptide vaccine S-588210

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.